West Pharmaceutical Services, Inc. logo

WST

West Pharmaceutical Services, Inc.

$323.88

Earnings Summary

Revenue
$771.3Mn
Net Profits
$188.5Mn
Net Profit Margins
24.44%
PE Ratio
38.33

Highlights

Revenue:

West Pharmaceutical Services, Inc.’s revenue jumped 6.59% since last year same period to $771.3Mn in the Q2 2022. On a quarterly growth basis, West Pharmaceutical Services, Inc. has generated 7.13% jump in its revenue since last 3-months.

Net Profits:

West Pharmaceutical Services, Inc.’s net profit jumped 0.64% since last year same period to $188.5Mn in the Q2 2022. On a quarterly growth basis, West Pharmaceutical Services, Inc. has generated 8.46% jump in its net profits since last 3-months.

Net Profit Margins:

West Pharmaceutical Services, Inc.’s net profit margin fell -5.58% since last year same period to 24.44% in the Q2 2022. On a quarterly growth basis, West Pharmaceutical Services, Inc. has generated 1.24% jump in its net profit margins since last 3-months.

PE Ratio:

West Pharmaceutical Services, Inc.’s price-to-earnings ratio after this Q2 2022 earnings stands at 38.33.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the West Pharmaceutical Services, Inc. post its latest quarter earnings

EPS Estimate Current Quarter
2.31
EPS Estimate Current Year
2.31

Highlights

EPS Estimate Current Quarter:

West Pharmaceutical Services, Inc.’s earning per share (EPS) estimates for the current quarter stand at 2.31 - a 4.52% jump from last quarter’s estimates.

EPS Estimate Current Year:

West Pharmaceutical Services, Inc.’s earning per share (EPS) estimates for the current year stand at 2.31.

Key Ratios

Key ratios of the West Pharmaceutical Services, Inc. post its Q2 2022 earnings

Earning Per Share (EPS)
2.47
Return on Assets (ROA)
0.16
Return on Equity (ROE)
0.32
Dividend Per Share (DPS)
0.69

Highlights

Earning Per Share (EPS):

West Pharmaceutical Services, Inc.’s earning per share (EPS) jumped 0.41% since last year same period to 2.47 in the Q2 2022. This indicates that the West Pharmaceutical Services, Inc. has generated 0.41% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. West Pharmaceutical Services, Inc.’s return on assets (ROA) stands at 0.16.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. West Pharmaceutical Services, Inc.’s return on equity (ROE) stands at 0.32.

Dividend Per Share (DPS):

West Pharmaceutical Services, Inc. declared 0.69 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-07-28
2.21
2.47
11.76%
2022-04-28
2.12
2.3
8.49%

Company Information

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With almost 10,000 team members across 50 sites worldwide, West helps support its customers by delivering over 40 billion components and devices each year.

Organisation
West Pharmaceutical Services, Inc.
Headquarters
Exton, Pennsylvania, US
Employees
9.2K
Industry
Health Technology
CEO
Eric Green